CSIMarket


Ani Pharmaceuticals Inc  (ANIP)
Other Ticker:  
 

Ani Pharmaceuticals Inc

ANIP's Fundamental analysis








Looking into Ani Pharmaceuticals Inc growth rates, revenue grew by 28.7 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 507

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Ani Pharmaceuticals Inc's net income grew by 1165.25 % in I. Quarter 2024 year on year, above company average,

More on ANIP's Growth


Ani Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Ani Pharmaceuticals Inc PEG ratio is at -0.19 Company is currently trading with Price to Cash flow multiple of 7.29 in trailing twelve-month period.
Company
37.87
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.27.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


More on ANIP's Valuation
 
 Total Debt (Millions $) 285
 Dividend TTM ($) 0.09 $
 Dividend Yield TTM (%) 0.15 %
 Revenue/Employee (TTM) $ 755,416
 Net Income/Employee (TTM) $ 51,893
 Receivable Turnover (TTM) 3.02
 Tangible Book Value (Per Share $) 11.72

Ani Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Ani Pharmaceuticals Inc PEG ratio is at -0.19 Company is currently trading with Price to Cash flow multiple of 7.29 in trailing twelve-month period.
Company
37.87
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.27.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.

Ani Pharmaceuticals Inc Price to Book Ratio is at 2.59 lower than Indusry Avg. of 74.64. and higher than S&P 500 Avg. of 0.01

More on ANIP's Valuation

  Market Capitalization (Millions $) 1,172
  Shares Outstanding (Millions) 19
  Employees 685
  Revenues (TTM) (Millions $) 517
  Net Income (TTM) (Millions $) 36
  Cash Flow (TTM) (Millions $) 161
  Capital Exp. (TTM) (Millions $) -21
  Total Debt (Millions $) 285
  Dividend TTM ($) 0.09 $
  Dividend Yield TTM (%) 0.15 %
  Revenue/Employee (TTM) $ 755,416
  Net Income/Employee(TTM) $ 51,893
  Receivable Turnover Ratio (TTM) 3.02
  Tangible Book Value (Per Share $) 11.72

  Market Capitalization (Millions $) 1,172
  Shares Outstanding (Millions) 19
  Employees 685
  Revenues (TTM) (Millions $) 517
  Net Income (TTM) (Millions $) 36
  Cash Flow (TTM) (Millions $) 161
  Capital Exp. (TTM) (Millions $) -21


    ANIP's Profitability Comparisons
Ani Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2024 to 14.78 % from 5.11 % in IV. Quarter.

Ani Pharmaceuticals Inc net profit margin of 13.25 % is currently ranking no. 26 in Major Pharmaceutical Preparations industry, ranking no. 58 in Healthcare sector and number 806 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.95
  Total Debt to Equity (MRQ) 0.63
  Tangible Leverage Ratio (MRQ) 2.03
  Asset Turnover Ratio (TTM) 0.58
  Inventory Turnover Ratio (TTM) 1.77



Ani Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in I. Quarter 2024 to 14.78 % from 5.11 % in IV. Quarter.

Ani Pharmaceuticals Inc net profit margin of 13.25 % is currently ranking no. 26 in Major Pharmaceutical Preparations industry, ranking no. 58 in Healthcare sector and number 806 in S&P 500.

More on ANIP's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com